ClearPoint Neuro, Inc.
CLPT
$9.42
-$0.09-0.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.41M | 8.86M | 9.22M | 8.49M | 7.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.41M | 8.86M | 9.22M | 8.49M | 7.77M |
| Cost of Revenue | 4.01M | 3.26M | 3.66M | 3.35M | 3.01M |
| Gross Profit | 6.40M | 5.60M | 5.56M | 5.13M | 4.76M |
| SG&A Expenses | 8.41M | 7.42M | 7.41M | 7.92M | 7.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.66M | 14.14M | 14.90M | 14.65M | 13.41M |
| Operating Income | -5.25M | -5.28M | -5.68M | -6.16M | -5.64M |
| Income Before Tax | -7.78M | -5.88M | -5.81M | -6.01M | -5.42M |
| Income Tax Expenses | 4.00K | 8.00K | 25.00K | 18.00K | -32.00K |
| Earnings from Continuing Operations | -7.79M | -5.89M | -5.84M | -6.03M | -5.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.79M | -5.89M | -5.84M | -6.03M | -5.39M |
| EBIT | -5.25M | -5.28M | -5.68M | -6.16M | -5.64M |
| EBITDA | -4.93M | -5.21M | -5.28M | -6.06M | -5.40M |
| EPS Basic | -0.27 | -0.21 | -0.21 | -0.22 | -0.20 |
| Normalized Basic EPS | -0.13 | -0.13 | -0.13 | -0.14 | -0.12 |
| EPS Diluted | -0.27 | -0.21 | -0.21 | -0.22 | -0.20 |
| Normalized Diluted EPS | -0.13 | -0.13 | -0.13 | -0.14 | -0.12 |
| Average Basic Shares Outstanding | 28.85M | 28.43M | 28.26M | 27.72M | 27.59M |
| Average Diluted Shares Outstanding | 28.85M | 28.43M | 28.26M | 27.72M | 27.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |